New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases
Language English Country United Arab Emirates Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
29623837
DOI
10.2174/1389450119666180406110743
PII: CDT-EPUB-89569
Knihovny.cz E-resources
- Keywords
- PUMA, brain, hearth, ionizing radiation, radioprotection, small molecule inhibitor.,
- MeSH
- Apoptosis drug effects genetics MeSH
- Molecular Targeted Therapy methods MeSH
- Cardiovascular Agents pharmacology therapeutic use MeSH
- Cardiovascular Diseases drug therapy pathology MeSH
- Humans MeSH
- Tumor Suppressor Protein p53 antagonists & inhibitors genetics metabolism MeSH
- Neoplasms genetics radiotherapy MeSH
- Neurodegenerative Diseases drug therapy pathology MeSH
- Neuroprotective Agents pharmacology therapeutic use MeSH
- DNA Damage drug effects radiation effects MeSH
- Apoptosis Regulatory Proteins antagonists & inhibitors metabolism MeSH
- Proto-Oncogene Proteins antagonists & inhibitors metabolism MeSH
- Radiation Injuries prevention & control MeSH
- Radiation-Protective Agents pharmacology therapeutic use MeSH
- Signal Transduction drug effects genetics MeSH
- Radiation Tolerance drug effects MeSH
- Protein Binding drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- BBC3 protein, human MeSH Browser
- Cardiovascular Agents MeSH
- Tumor Suppressor Protein p53 MeSH
- Neuroprotective Agents MeSH
- Apoptosis Regulatory Proteins MeSH
- Proto-Oncogene Proteins MeSH
- Radiation-Protective Agents MeSH
- TP53 protein, human MeSH Browser
This review summarizes recent progress in understanding the role of p53-upregulated mediator of apoptosis (PUMA) in molecular pathways with respect to its potential therapeutic applications. Particular emphasis is given to the PUMA´s role in ionizing radiation-induced signalling as radiotoxicity of normal tissue is mediated mostly via apoptosis. PUMA and its p53-dependent and p53- independent induction are described and potential use as a new target for the development of radioprotective agents is suggested. Further implications, including targeting PUMA to prevent and treat cardiovascular and neurodegenerative diseases, are also discussed together with an overview of other therapeutic applications. Finally, basic chemical structures for the development of novel PUMA modulators such as pifithrine derivatives, kinase inhibitors or modulators of Bcl-2 protein family are described.
References provided by Crossref.org
Second-generation piperazine derivatives as promising radiation countermeasures
Substituted Piperazines as Novel Potential Radioprotective Agents
